Skip to content

Development of a Visio-behavioral Scale to Evaluate Visual Abilities of Patients With Profound Multiple Intellectual Disabilities (PLH-Vision)

Development of a Visio-behavioral Scale to Evaluate Visual Abilities of Patients With Profound Multiple Intellectual Disabilities (PLH-Vision)

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT03040609
Acronym
PLH-Vision
Enrollment
232
Registered
2017-02-02
Start date
2017-07-20
Completion date
2021-04-13
Last updated
2021-09-23

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Profound Multiple Intellectual Disabilities

Keywords

Profound Multiple Intellectual Disabilities, Visual-Behavioral Scale

Brief summary

The main objective of this study is to develop and validate a visio-behavioral scale of visual abilities for subjects with profound multiple intellectual disabilities. The secondary objectives of the study are: * to validate the structure of the scale. * to evaluate the reproducibility of scale with the intra- and inter-examiners, and the influence of the different professions of examiners. * to evaluate the feasibility of visio-behavioral scale. * to evaluate the sensitivity to change. * to study the uniformity of use of the scale depending on the type of patients (age, disability level, pathology). * to study the prevalence of the visual disorder in profound multiple intellectual disabilities subjects.

Detailed description

This study includes 3 phases: * Elaboration of a list of behavioral items by a group of multi-disciplinary expertise (physicians, nurses, caregivers, ophthalmologies, orthoptists) based on their clinical experiences. * Development of the scale based on the sample obtained by a prospective multicenter research trial. * Validation of the sample obtained by a prospective transversal multicenter study. This study will be performed in 5 centers in France. The enrollment of patients planned for 24 months targeting 310 patients. The duration of follow-up of the study for each patient will be varied according to the group of patients, il will be 1 day for group 1, 2 weeks for group 2, or 6 months for group 3.

Interventions

BEHAVIORALVisual-behavioral Scale at day 1

To perform the classification with the scale by caregiver.

BEHAVIORALTest-retest at the end of 2 weeks

To perform the classification with the scale by orthoptist at the end of 2 weeks

BEHAVIORALTest at 6 months

To perform the classification with the scale by orthoptist at the end 6 months.

Sponsors

Assistance Publique - Hôpitaux de Paris
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
3 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Causal brain injury occurred before the age of 3 years. * Severe or deep mental retardation as defined by DSM IV. * Motor impairment: para / tetraparesis, hemiparesis, ataxia, or extrapyramidal motor disorders. * Score of Gross Motor Function Classification System \[Palisano 1997\] is III, IV or V. * Score of Functional Independence Measure \< 55. * Subject aged ≥3 years (because the visio-behavioral scale is not adapted for children younger than 3 years). * Beneficiary of a social protection. * Written consent signed by guardian or legal representative, or parents in case of a minor subject.

Exclusion criteria

* Acute intercurrent pathology precluding examinations. * Patient with hypersensitivity to tropicamide, atropine or benzalkonium chloride. * Angle closure glaucoma suspect patient. * Patient with severe hypertension. * Short life expectancy.

Design outcomes

Primary

MeasureTime frameDescription
Concordance of classificationthroughout the study: 31 monthsStatistical analysis: concordance between the classification obtained by caregiver with the scale, and the classification obtained by orthoptist-ophthalmology.

Secondary

MeasureTime frameDescription
Reproducibility of scalethroughout the study: 31 monthsStatistical analysis to evaluate the reproducibility of scale with the intra- and inter-examiners, and the influence of the different professions of examiners.
Feasibility of visio-behavioral scalethroughout the study: 31 monthsStatistical analysis to evaluate by the proportion of patients who have the complet examination, the average of time to all examens, the tolerance data. feasibility of visio-behavioral scale.
Structure of the scalethroughout the study: 31 monthsStatistical analysis to validate the structure of the scale.
Uniformity of use of the scalethroughout the study: 31 monthsStatistical analysis to assess the uniformity of use of the scale depending on the type of patients (age, disability level, pathology).
Prevalence of the visual disorderthroughout the study: 31 monthsStatistical analysis to study the prevalence of the visual disorder in profound multiple intellectual disabilities subjects.
Sensitivity to changethroughout the study: 31 monthsStatistical analysis to evaluate the sensitivity to change.

Countries

France

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026